Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul Editor Louis Juricic Stock Markets Published 06/09/2025, 04:18 PM ...

The updated guidance highlights myocarditis and pericarditis, two types of heart inflammation, as possible adverse events ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than those who received the Moderna shot, a new study of 1.47 million people found.